Skip to main content

Table 2 Prevalence of albuminuria, estimated glomerular filtration rate (eGFR) and stages of CKD stratified by clinical conditions

From: Prevalence of chronic kidney disease among the high risk population in South-Western Ghana; a cross sectional study

Variable Diabetes (n = 120) Hypertension (n = 65) Hypertension and diabetes (n = 23) Total (n = 208) P-value
uPCR
 <3 mg/mmol 102 (85.0) 52 (80) 7 (30.4) 161 (77.4) p < 0.001
 3–30 mg/mmol 18 (15.0) 10 (15.4) 15 (65.2) 43 (20.7)  
 >30 mg/mmol 0 (0.0) 3 (4.6) 1 (4.3) 4 (1.9)  
eGFR, mL/min/1.73 m2 n (%)
 ≥90 39 (33) 16 (25) 5 (22) 60 (29) p < 0.001
 60–89 54 (45) 39 (60) 5 (22) 98 (47)  
 45–59 15 (13) 1 (1.5) 3 (13) 19 (9.1)  
 30–44 9 (7.5) 5 (7.7) 4 (17) 18 (8.7)  
 15–29 3 (2.5) 4 (6.2) 6 (26) 13 (6.2)  
 <15 0 0.0) 0 (0.0) 0 (0.0) 0 (0.0)  
CKD n (%)
 Stage 1: eGFR ≥90 + Alb 1 (0.8) 1 (1.5) 1 (4.3) 3 (1.4) 0.16
 Stage 2: eGFR 60–89 + Alb 4 (3.3) 3 (4.6) 3 (13.0) 10 (4.8)  
 Stage 3a: eGFR 45–59 15 (12) 1 (1.5) 3 (13.0) 19 (9.1)  
 Stage 3b: eGFR 30–44 9 (7.5) 5 (7.7) 4 (17) 18 (8.7)  
 Stage 4: eGFR15–29 3 (2.5) 4 (6.2) 6 (26) 13 (6.3)  
 Stage 5: eGFR < 15 0 0 0 0  
Total CKD, n (%)
 (Stages 1–5) 32 (27) 14 (22) 17 (74) 63 (30)  
  1. Note to authors: the reference here should be a citation and should be to the earlier version of the guidelines that used the staging terminology
  2. We include stages as described in earlier KDIGO guidelines (KDIGO 2013) for the purposes of comparison with other studies
  3. uPCR rine protein-creatinine ratio, eGFR estimated GFR, CKD chronic kidney disease